Literature DB >> 14601846

Ocular manifestations of Wegener's granulomatosis. Analysis of nine cases.

Jyotirmay Biswas1, Kalpana Babu, Lingam Gopal, Subramanian Krishnakumar, Sankarasubaiyan Suresh, Subramaniam Ramakrishnan.   

Abstract

PURPOSE: To report a series of nine patients of Wegener's granulomatosis (WG) with diverse ocular and systemic manifestations.
METHODS: Retrospective analysis of nine consecutive patients seen between 1987 and 2002.
RESULTS: The mean age at the time of diagnosis was 43.89 years (range: 33-56 years). Redness, pain and photophobia (8 patients) were the common presenting complaints. Sinusitis (6 patients) and arthralgia (6 patients) were the commonly associated systemic complaints. Necrotising scleritis with peripheral keratopathy (6 patients) was the most common ocular sign. Serum antibodies against the cytoplasmic component of neutrophils and monocytes (cANCA) were positive in 7 of 8 patients. Biopsy diagnosis was done in one patient for whom cANCA was not done. Cyclophosphamide and corticosteroids alleviated the symptoms in 6 patients. Ocular and systemic condition remained stable in 7 patients. One patient expired due to the severity of the disease and another patient was lost to follow-up.
CONCLUSIONS: Scleritis with peripheral corneal involvement was the most commonly observed ocular manifestation of WG in our series. cANCA was a useful adjunct in the diagnosis of WG. When clinical and serologic findings were inconclusive, biopsy remained indispensable. A combination of cyclophosphamide and corticosteroids is essential and critical not only for the ocular condition but also for the survival of the patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601846

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  7 in total

1.  Bilateral scleromalacia perforans and peripheral corneal thinning in Wegener's granulomatosis.

Authors:  S C Reddy; I Tajunisah; T Rohana
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

2.  Clinical significance of ocular manifestations in granulomatosis with polyangiitis: association with sinonasal involvement and damage.

Authors:  Andrea Hinojosa-Azaola; Annette García-Castro; Alejandra Juárez-Flores; Claudia Recillas-Gispert
Journal:  Rheumatol Int       Date:  2019-01-31       Impact factor: 2.631

3.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

4.  The Development of Keratopathy after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study.

Authors:  Hung-Jui Hsu; Chia-Yi Lee; Kun-Lin Yang; Hung-Chi Chen; Chi-Chin Sun; Jing-Yang Huang; Hung-Yu Lin; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2019-04-05       Impact factor: 3.390

Review 5.  Systemic immunosuppressive therapies for uveitis in developing countries.

Authors:  Hitesh Agrawal; Hien Doan; Brandon Pham; Amit Khosla; Manohar Babu; Peter McCluskey; Quan Dong Nguyen; Virender Sangwan; Subhakar Reddy; Sujata Sawhney; Mudit Tyagi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

6.  Simultaneous Unilateral Presentation of Three Different Ocular Manifestations of Granulomatosis with Polyangiitis.

Authors:  Ali Salehi; Farzan Kianersi; Heshmatollah Ghanbari; Zahra Dastborhan; Ebrahim Gerami; Elnaz Pirmoazzen
Journal:  J Ophthalmic Vis Res       Date:  2018 Apr-Jun

7.  Antineutrophil cytoplasmic antibody-positive scleritis: Clinical profile of patients from a tuberculosis-endemic region.

Authors:  Parthopratim Dutta Majumder; Sridharan Sudharshan; Amala Elizabeth George; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.